Competitor Analysis: Cardiovascular Peptides

The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. The report includes a compilation of current active projects in research and development of cardiovasuclar peptides.